\addcontentsline{toc}{chapter}{Appendices}
\appendix

\chapter{Interpretation of Morphogen Gradients by a Bistable Circuit}
\label{appendix:double-exclusive}
\includepdf[pages=1-51, offset=75 -90, scale=0.85, frame,
        clip,trim=20mm 5mm 20mm 15mm,
        pagecommand={}, addtotoc={
                2,section,1,Supplementary Figures,appendix:double-exclusive:figures,
                18,section,1,Supplementary Methods,appendix:double-exclusive:methods,
                19,subsection,2,Differential Equation Models \& Parameter Inference,appendix:double-exclusive:inference,
                40,subsection,2,Bistability Analysis,appendix:double-exclusive:bistability,
                42,subsection,2,Boundary Experiments,appendix:double-exclusive:boundaries,
                50,subsection,2,Models of the Exclusive Receiver Relay Circuits,appendix:double-exclusive:relay},
        addtolist={
                2, figure, {\textit{Supplementary Figure 1}\quad Circuit variants}, fig:double-exclusive:variants,
                4, figure, {\textit{Supplementary Figure 2}\quad Raw timecourse fluorescence traces}, fig:double-exclusive:plate-data,
                15, figure, {\textit{Supplementary Figure 13}\quad Hysteresis flow cytometry experiments}, fig:double-exclusive:flow-hysteresis,
                41, figure, {\textit{Supplementary Figure 25}\quad Bifurcation curves for uniform and protected degradation models}, fig:double-exclusive:degradation-models,
                41, figure, {\textit{Supplementary Figure 26}\quad ifurcation curve insensitivity specific growth rate $\gamma_0$}, fig:double-exclusive:growth-rate-sensitivity
}]{publications/double-exclusive-si.pdf}

\chapter{Parameter Inference with Bifurcation Diagrams}
\label{appendix:inference}
\includepdf[pages=1-6, offset=75 -90, scale=0.85, frame,
        clip,trim=33mm 20mm 33mm 20mm,
        pagecommand={}, addtotoc={
                1,section,1,Bifurcation Diagrams as Tangent Fields,appendix:tangent-fields,
                2,section,1,Bifurcation Measure Properties,appendix:bifurcation-measure,
                3,section,1,Leibniz Rule for Space Curves,appendix:leibniz-rule,
                5,section,1,Application to the Double Exclusive Model,appendix:more-complex-model,
                6,section,1,Extension for Hopf Bifurcations,appendix:hopf-measure},
        addtolist={
                1, figure, {\textit{Supplementary Figure 1}\quad Two implicit surfaces $f_{\theta}(z)=0$ and $g_{\theta}(z)=0$ in $\mathbb{R}^3$ intersecting to form a space curve which is tangent to field $\tangent(z)$ and perpendicular to gradients $\partial_{z}f_{\theta}$ and $\partial_{z}g_{\theta}$}, fig:implicit-surfaces,
                2, figure, {\textit{Supplementary Figure 2}\quad Left/Right : Determinant $\Det$ and tangent field $\tangent(z)$ for the saddle-node/pitchfork models for some set values of $\theta$ revealing that $\Det=0$ defines bifurcations}, fig:determinant-field,
                5, figure, {\textit{Supplementary Figure 3}\quad Bifurcation inference for the \emph{double exclusive reporter}. A. Optimal parameter estimates $\theta^*$ for the targets $\targets=\{1,2\}$ (indicated by yellow lines in panel B) reveal four regions  with two geometrically different regimes: mutual activation (region 1) and mutual inhibition (regions 2-4). B. Example bifurcation diagrams indicate that region 2 has swapped kinetics between $L$ and $T$ to region 3. Region 4 has models with non-zero imaginary parts to eigenvalues indicating damped oscillations (shown in light green).},
                fig:double-exclusive-optima,
                6, figure, {\textit{Supplementary Figure 4}\quad Bifurcation measure $\measure(s)$ and eigenvalues $\lambda(s)$ along the arclength $s$ for two different bifurcation curves demonstrating how the measure detects non-zero imaginary parts $\Imag[\lambda]$ (onset of damped oscillations marked by circle) and sign changes in real parts $\Real[\lambda]$ (Hopf bifurcations marked by stars)},
                fig:hopf-measure
}]{publications/bifurcation-inference-si.pdf}

\chapter{Exploring Bifurcations between Phenotypes}
\label{appendix:exploring}
\section{Supplementary Tables}

\begin{landscape}
\begin{table}
\footnotesize
\begin{center}
\begin{tabular}{>{\centering\arraybackslash}p{0.6cm}>{\centering\arraybackslash}p{0.4cm}>{\centering\arraybackslash}p{0.7cm}>{\centering\arraybackslash}p{0.9cm}>{\centering\arraybackslash}p{0.9cm}>{\centering\arraybackslash}p{0.9cm}>{\centering\arraybackslash}p{1cm}>{\centering\arraybackslash}p{1cm}>{\centering\arraybackslash}p{1cm}>{\centering\arraybackslash}p{1cm}>{\centering\arraybackslash}p{2.1cm}>{\centering\arraybackslash}p{0.6cm}}
    \toprule
    Donor ID & Sex & Age & Primary cause of death & Multi-trauma & Days in hospital & BMI &CMV/ EBV/ TOXO& Smoking & Alcohol (u/day) & Antibiotics within 2 weeks of death & Steroids \\
    \midrule
    390C & F & 65-70 & ICH & \cmark & 2 & 30-35 & $+$/$+$/$-$ & ? & $<$1 & \xmark & \xmark \\
    403C & M & 50-55 & ICH & \cmark & 8 & 30-35 & $+$/$+$/$-$ & \cmark & $<$1 & Co, T & \xmark \\
    423C & M & 60-65 & ICH & \xmark & 2 & 20-25 & $-$/$+$/$-$ & \cmark & $>$9 & G, F & D \\
    412C & M & 70-75 & ICH & \xmark & 5 & 26-30 & $-$/$+$/$+$ & \cmark & $<$2 & A$^\star$ , F, G, C, Co & P$^\dagger$ \\
    428C & F  & 55-60 & ICH & \xmark & 3 & 20-25 & $-$/$+$/$-$ & \cmark & $>$9 & Co & \xmark \\
    \bottomrule
\multicolumn{12}{p{\linewidth}}{\vline height10pt width0pt
\relax F = Female; M = Male; ICH = intracranial haemorrhage; CMV = Cytomegalovirus; EBV = Epstein-Barr virus; TOXO = Toxoplasmosis; Co = Co-amoxiclav; A = Amoxicillin; T = Tazocin; F = Flucloxacillin; G = Gentamicin; D = Dexamethasone; C = Clarithromycin; \cmark = Yes; \xmark = No; ? = Not known;P = Prednisolone; $^\star$pre-admission, $^\dagger$pre-treatment}\\
\end{tabular}
\caption{Donor Metadata}
\label{table:donors}
\end{center}
\end{table}
\end{landscape}

\begin{table}
\footnotesize
\begin{center}
    \begin{tabular}{llll}
        \toprule
        Specificity & Fluorochrome & Clone & Source \\
        \midrule
        CD3 &  BUV395 & SK7 & BD \\
        CD8 & BUV563 & RPA-T8 & BD \\
        CD69 & BUV737 & FN50 & BD \\
        CD4 & BUV805 & SK3 & BD \\
        CD4 & BUV661 & SK3 & BD \\
        CD45 & BUV805 & HI30 & BD \\
        CD103 & BV421 & Ber-ACT8 & BD \\
        HLA-DR & BV510 & G46-6 & BD \\
        CD127 & PE-Cy7 & HIL-7R-M21 & BD \\
        CCR4 & BV605 & L291H4 & Biolegend \\
        CCR6 & BV650 & 11A9 & BD \\
        PD-1 & BV711 & EH12.1 & BD \\
        CD45RA & BV786 & HI100 & BD \\
        CCR10 & BB515 & 1B5 & BD \\
        CXCR3 & BB700 & 1C6/CXCR3 & BD \\
        CXCR5 & APC-R700 & RF8B2 & BD \\
        CCR7 & APC-Fire750 & G043H7 & Biolegend \\
        CD25 & APC & M-A251 & BD \\
        CD25 & APC & 2A3 & BD \\
        CD19 & BV570 & HIB19 & Biolegend \\
        IgM & PE & G20-127 & BD \\
        IgD & BUV395 & IA6-2 & BD \\
        Foxp3 & PE & 269D/C7 & BD \\
        Foxp3 & PE & PCH101 & eBioscience \\
        Helios & PE-Dazzle & 22F6 & Biolegend \\
        Zombie UV & - & - & Biologend \\
        \bottomrule
    \end{tabular}
\caption{Details of antibodies used in this study}
\label{table:panel}
\end{center}
\end{table}

\begin{table}
\footnotesize
\begin{center}
    \begin{tabular}{lrlll}
        \toprule
        & \multicolumn{4}{c}{Fluorochromes} \\
        \cmidrule{3-5}
         & Panels:&  A &  B &  C \\
        \cmidrule{3-5}
        Specificity & Donor:& 390C & 403C & 412C, 423C, 428C \\
        \midrule
        CD45 && BUV805 & - & - \\
        CD19 && - & - & BV570 \\
        IgM && - & - & PE \\
        IgD && - & - & BUV395 \\
        CD4 && \textbf{BUV661} & \textbf{BV805} & \textbf{BV805} \\
        CD3 &&  BUV395 & BUV395 & BUV395 \\
        CD8 && BUV563 & BUV563 & BUV563 \\
        CD69 && BUV737 & BUV737 & BUV737 \\
        CD103 && BV421 & BV421 & BV421 \\
        HLA-DR && BV510 & BV510 & BV510 \\
        CD127 && PE-Cy7 & PE-Cy7 & PE-Cy7 \\
        CCR4 && BV605 & BV605 & BV605 \\
        CCR6 && BV650 & BV650 & BV650 \\
        PD-1 && BV711 & BV711 & BV711 \\
        CD45RA && BV786 & BV786 & BV786 \\
        CCR10 && BB515 & BB515 & BB515 \\
        CXCR3 && BB700 & BB700 & BB700 \\
        CXCR5 && APC-R700 & APC-R700 & APC-R700 \\
        CCR7 && APC-Fire750 & APC-Fire750 & APC-Fire750 \\
        CD25 && APC & APC & APC \\
        Foxp3 && PE & PE & PE \\
        Helios && PE-Dazzle & PE-Dazzle & PE-Dazzle \\
        Zombie UV && Zombie UV & Zombie UV & Zombie UV \\
        \bottomrule
    \end{tabular}
\caption{Immunophenotyping panel designs used in the dataset}
\label{table:panels}
\end{center}
\end{table}